Concepedia

Laura Puzniak

LP

53

Publications

2.5K

Citations

27

H-Index

2001

Active since

Affiliations

Pfizer (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Kaiser Permanente

Becton Dickinson (United States)

University of Rhode Island

Laura Puzniak is an author at Pfizer (United States) specializing in medicine, epidemiology, and infection control.

ORCID

Top concepts

Publications per year

2001–2025

53

Publications

53

Ceftolozane/Tazobactam vs Polymyxin or Aminoglycoside-based Regimens for the Treatment of Drug-resistant Pseudomonas aeruginosa

Jason M. Pogue, Keith S. Kaye, Michael P. Veve et al. · Clinical Infectious Diseases · 2019 · 191 citations · Full text

Mortality Among US Patients Hospitalized With SARS-CoV-2 Infection in 2020

Lyn Finelli, Vikas Gupta, Tanaz Petigara et al. · JAMA Network Open · 2021 · 149 citations · Full text

Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study

Sara Y. Tartof, Jeff Slezak, Laura Puzniak et al. · The Lancet Respiratory Medicine · 2022 · 148 citations · Full text

, , +10

<i>Clostridium difficile</i> in the Intensive Care Unit: Epidemiology, Costs, and Colonization Pressure

Steven J. Lawrence, Laura Puzniak, Brooke N. Shadel et al. · Infection Control and Hospital Epidemiology · 2007 · 141 citations · Full text

Seasonal trends in COVID-19 cases, hospitalizations, and mortality in the United States and Europe

Timothy L. Wiemken, Farid Khan, Laura Puzniak et al. · Scientific Reports · 2023 · 133 citations · Full text

Rows per page

1–5 of 53